Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype
NCT ID: NCT02706210
Last Updated: 2017-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
160 participants
OBSERVATIONAL
2015-09-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
NCT06534658
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
NCT06827678
Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology
NCT02353845
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All the participants received a battery of neuropsychological tests to assess general mental status and other cognitive domains, including visual-spatial ability, executive function, language, memory, attention, and general intellectual ability. These tests included the CDR scale, the Mini-Mental State Examination(MMSE), the Montreal Cognitive Assessment(MoCA), clock drawing test (CDT), Auditory Verbal Learning Test (AVLT), activities of daily living scale(ADL) and Hamilton Depression Scale and HIS. All these evaluations were performed by two attending neurologists.
All participants were scanned on a 3.0 T Siemens scanner within a single session.
Each participant received a magnetization prepared rapidly acquired gradient echo (MPRAGE) T1-weighted scan (repetition time \[TR\], 1900 ms; echo time \[TE\], 2.2 ms; inversion time, 900 ms; matrix, 256×256; number of excitations, 1; thickness, 1 mm; 176 slices) Resting state functional images were collected using an echo-planar imaging (EPI) sequence with the following parameters: repetition time (TR)= 2000 ms; echo time (TE)=40 ms; flip angle=90°; number of slices=28; slice thickness=4 mm; gap=1 mm; voxel size=4×4×4 mm3; and matrix=64×64. Participants were asked to lie quietly in the scanner with their eyes closed during the data acquisition. This scan lasted for 478 s. For each subject, the first five volumes were discarded to allow for T1 equilibration effects and the adaptation of the subjects to the circumstances, leaving 234 images for further analysis.
The diffusion weighted imaging scans were acquired on a 3.0T Siemens Tim Trio MRI scanner. Three diffusion echo-planar imaging sequence with one zero-weighted image (b =0 s/mm2) and thirty diffusion sensitizing orientations (b =1000 s/mm2) was used with the following specifications: slice thickness=2 mm; 90 slices; repetition time = 11000 ms; echo time = 98 ms; voxel size = 2 mm isotropic; flip angle=90°; acquisition matrix = 128 mm×116 mm .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vascular cognitive disorders pre-dementia (VCD-P)
No interventions assigned to this group
amnestic mild cognitive impairment (aMCI)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Right-hand Chinese Han people
2. Sufficient with Mandarin language
* For VCD-P group,
1. Clinical diagnosis of Vascular cognitive disorders
2. Between the stage of cognitive normal and dementia
3. Clinical diagnosis of subcortical vascular diseases
* For aMCI group
1. Clinical diagnosis of aMCI
2. Between the stage of cognitive normal and dementia
3. The hippocampal atrophy confirmed by structural MRI
Exclusion Criteria
* a suffering of visual abnormalities, severe aphasia or palsy
* any medical or psychological conditions
45 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Natural Science Foundation of China
OTHER_GOV
Mudanjiang Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yang Yu
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology, Hongqi Hospital of Mudanjiang Medical Universiy
Mudanjiang, Heilongjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Changhao Yin
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Yu Y, Zhao W, Li S, Yin C. MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study. BMJ Open. 2017 Mar 8;7(3):e013432. doi: 10.1136/bmjopen-2016-013432.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MudanjiangMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.